Swiftmerge Acquisition Corp. (IVCP)
| Previous Close | 10.80 |
| Open | 10.81 |
| Bid | 10.79 x 100 |
| Ask | 10.81 x 100 |
| Day's Range | 10.80 - 10.80 |
| 52 Week Range | 10.00 - 12.20 |
| Volume | |
| Avg. Volume | 16,874 |
| Market Cap | 73.871M |
| Beta (5Y Monthly) | 0.01 |
| PE Ratio (TTM) | 49.09 |
| EPS (TTM) | 0.22 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Insider MonkeyFarallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks
In this article, we discuss Farallon Capital: a global and diversified hedge fund and its top stock picks. If you want to skip our detailed analysis of these stocks, go directly to the Top 5 Stock Picks of Farallon Capital. Risk arbitrage or merger arbitrage is one of the most popular strategies that hedge funds […]
Business WireHDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.
NEW YORK & VERO BEACH, Fla., August 11, 2023--HDL Therapeutics, Inc. ("HDL Therapeutics"), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy the Plasma Delipidation System (PDS-2™ System) for reducing coronary atheroma in patients with homozygous familial hypercholesterolemia (HoFH), has signed a definitive merger agreement with Swiftmerge Acquisition Corp. (NASDAQ: IVCP) ("Swiftmerge"), a special purpose acquisition company with a disruptive consumer
